FARMINGTON, Conn., Nov. 5, 2012 \/PRNewswire-iReach\/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion. <\/p>\n
(Photo: http:\/\/photos.prnewswire.com\/prnh\/20121105\/CG06410<\/a>) <\/p>\n From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research partner BioPharm Reports,, is offering a special discount on all BioPharm market research reports, forecasts, and studies. How will your organization use the critical information contained within these reports to support growth and sales strategies and seize market opportunities in the life sciences field? <\/p>\n Life Science Software: Markets and Opportunities <\/p>\n This report is the result of six life science studies examining the use of specialist software and databases related to the conduct of PCR, DNA sequencing, DNA microarray, flow cytometry, mass spectrometry and disease biomarker studies. In total, 2,200 end-users in 70 countries participated in these studies. This is an excellent study for software developers and vendors to identify market opportunities in the life science field. <\/p>\n The major components of the report are as follows: breakdown of end-user practices in use of life science software and databases to conduct studies of PCR, DNA microarray, DNA sequencing, mass spectrometry, flow cytometry, and disease biomarker; breakdown of end-user practices by field (e.g. biotech, hospital, defence, pharmaceuticals, food and drink); breakdown by region, including Europe, North America, Asia and RoW countries; list of participating organizations and anticipated growth; and estimates of global market sizes of software and databases related to the respective life science fields. <\/p>\n An Executive Summary for this report and free sample pages from the full document are available at http:\/\/www.giiresearch.com\/report\/bph251023-life-science-software-markets-opportunities.html<\/a> <\/p>\n DNA Microarray 2012: A Focus on Sales Growth <\/p>\n Based on the prevailing and emerging market conditions in the DNA microarray field, this report was created to assist marketing and sales with the identification of new opportunities. The analysis and report findings provide a \"focus on sales growth\" to developers and vendors in the microarray field and the changes driving these developments. <\/p>\n Market areas covered in this study include: routine use, suppliers, methods, applications, preferred companies, products, strengths, weaknesses, financial budgets, budget breakdown, future budget breakdown, future budgets, consumables, quality control, challenges, innovation, recent innovations, future innovation, biomarkers, organizations, fields, bioinformatics software, purpose, samples and sample preparation. <\/p>\n<\/p>\n See the article here: FARMINGTON, Conn., Nov. 5, 2012 \/PRNewswire-iReach\/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. Continue reading
\nMarkets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"